SONOMA PHARMACEUTICALS, INC. Other Comprehensive Income (Loss), Net of Tax
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Other Comprehensive Income (Loss), Net of Tax of -$2.92 million for the 12-month period ending 2021-03-31, per its 10-K filed 2021-07-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2021-07-14
- SONOMA PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for fiscal 2021 was -$2.92M.
- SONOMA PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for fiscal 2020 was -$4.57M.
- SONOMA PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for fiscal 2019 was -$12.17M.
- SONOMA PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for fiscal 2018 was -$14.13M, a 257.82% decline from fiscal 2017.
| Period end | Other Comprehensive Income (Loss), Net of Tax 12 month | Other Comprehensive Income (Loss), Net of Tax 12 month as first filed |
|---|---|---|
| 2021-03-31 | -$2.92M 10-K · filed 2021-07-14 | |
| 2020-03-31 | -$4.57M 10-K · filed 2021-07-14 | -$4.21M 10-K · filed 2020-07-10 |
| 2019-03-31 | -$12.17M 10-K · filed 2020-07-10 | |
| 2018-03-31 | -$14.13M 10-K · filed 2019-07-01 | |
| 2017-03-31 | $8.95M 10-K · filed 2018-06-26 | |
| 2016-03-31 | -$10.51M 10-K · filed 2017-06-28 | |
| 2015-03-31 | -$8.64M 10-K · filed 2016-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |